Surgical treatment of idiopathic megarectum in constipated children

Igor V Kirgizov1, Sergey V Minaev2, Ilya Shishkin1

  • 1Department of Pediatric Surgery, National Medical Research Center of Children's Health, Lomonosov Avenue, 2, building 1, Moscow, Russian Federation.

Insights

Laparoscopic low anterior resection is superior to the Soave procedure for treating pediatric idiopathic megarectum, significantly reducing complications like anastomosis leakage and frequent loose stools with soiling. This surgical approach offers better functional outcomes for children with chronic constipation.

Area of Science:

  • Pediatric surgery
  • Gastroenterology
  • Colorectal surgery

Background:

  • Chronic constipation in children is often linked to primary megarectum.
  • Idiopathic megarectum requires effective surgical interventions.

Purpose of the Study:

  • To compare surgical outcomes for idiopathic megarectum in children.
  • To evaluate the efficacy of Soave pull-through versus laparoscopic low anterior resection.

Main Methods:

  • Retrospective comparative study of 52 children with idiopathic megarectum.
  • Two groups: Soave pull-through (n=23) and laparoscopic low anterior resection with stapled anastomosis (n=29).
  • Evaluations included clinical assessment, manometry, colonoscopy, and contrast enema.

Main Results:

  • Anastomosis leakage occurred in 26.1% of Soave patients vs. 3.5% of laparoscopic patients (P=0.049).
  • Frequent loose stools with soiling were significantly higher in the Soave group (60.9%) compared to the laparoscopic group (13.8%) (P=0.001).
  • No significant difference in long-term constipation rates between groups.

Conclusions:

  • Laparoscopic low anterior resection with ultrasound guidance is a preferred surgical option for pediatric idiopathic megarectum.
  • This approach yields good functional results and fewer complications compared to the Soave procedure.
  • The study highlights the benefits of minimally invasive techniques in pediatric colorectal surgery.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
829
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
295
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
996
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
949